Scinai Immunotherapeutics Ltd. - American Depositary Shares (SCNI)

Scinai Immunotherapeutics Ltd is a biotechnology company focused on the development of innovative therapeutic solutions aimed at treating various types of cancers and autoimmune diseases

The company leverages advanced immunotherapy techniques to harness the body’s immune system, enhancing its ability to identify and combat disease. By conducting research and clinical trials, Scinai seeks to bring novel treatments to market that can improve patient outcomes and offer hope for conditions that currently have limited treatment options. Their commitment to scientific advancement in the field of immunotherapy positions them as a key player in the evolving landscape of medical therapeutics.